Crinetics Pharmaceuticals, Inc.
CRNXDelisted Sep 1, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Crinetics Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 94 | 118 | +24 |
| Shares | 33.6M | 44.3M | +10.6M (+31.6%) |
| Value | $708.2M | $1.26B | +$548.4M (+77.4%) |
New holders (31)
Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (7)
Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Vivo Capital, LLC | 517,280 | $10.9M |
| Blackstone Group Inc. | 24,334 | $512.0K |
| Point72 Hong Kong Ltd | 2,438 | $51.0K |
| Meeder Asset Management Inc | 1,988 | $42.0K |
| Jacobi Capital Management LLC | 1,500 | $32.0K |
| Penserra Capital Management LLC | 885 | $18.0K |
| Parallel Advisors, LLC | 6 | $0 |